Neurofilament heavy chain (NfH) levels have been less investigated compared to the NfLs and even though the studies outlined a significant difference between relapsing–remitting MS and secondary progressive MS, this difference does not seem to have any clinical significance [25]. The gene discussed is NEFH; the disease is secondary progressive multiple sclerosis.